Zoetis Inc.

Pharmaceuticals
United States
Earnings Per Share Growth (%)-41.38%
Cost of Goods Sold (US$ Millions)$1,738
Current Liabilities (US$ Millions)$1,781
Total Assets (US$ Millions)$3,830
Long Term Debt$4,463
Return on Equity25.86%
Revenue (US$ Millions)$4,765
Total Company Assets$7,913
Revenue Growth (%)-0.42%
Net Income (US$ Millions)$339
Earnings Per Share (US$)($41.38)
Total Equity (US$ Millions)$1,068
Profit Margin (%)7.11%
Debt To Equity Ratio (%)4.18%
Inventory Turnover$1,467